Nifty
Sensex
:
:
26172.40
85567.48
206.00 (0.79%)
638.12 (0.75%)

Miscellaneous

Rating :
72/99

BSE: 506414 | NSE: Not Listed

355.30
22-Dec-2025
  • Open
  • High
  • Low
  • Previous Close
  •  354
  •  359
  •  347.5
  •  353.50
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  50012
  •  17786124
  •  359
  •  0

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,045.68
  • 9.34
  • 5
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,100.70
  • 0.70%
  • 2.67

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 64.09%
  • 1.20%
  • 29.77%
  • FII
  • DII
  • Others
  • 0.02%
  • 0.00%
  • 4.92%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 11.73
  • 4.47
  • 10.29

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 18.56
  • 6.00
  • 43.45

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 11.05
  • -

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 10.69
  • 13.24
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.74
  • 2.16
  • 2.18

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 14.26
  • 17.23
  • 20.04

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 25
Sep 24
Var%
Jun 25
Jun 24
Var%
Mar 25
Mar 24
Var%
Dec 24
Dec 23
Var%
Net Sales
130.22
95.03
37.03%
136.26
78.13
74.40%
139.85
97.34
43.67%
156.47
98.97
58.10%
Expenses
103.59
76.25
35.86%
108.03
77.33
39.70%
102.90
91.97
11.88%
103.20
73.85
39.74%
EBITDA
26.64
18.78
41.85%
28.23
0.80
3,428.75%
36.94
5.37
587.90%
53.27
25.12
112.06%
EBIDTM
20.45%
19.76%
20.72%
1.03%
26.42%
5.52%
34.04%
25.38%
Other Income
5.43
2.88
88.54%
8.77
2.82
210.99%
3.89
5.38
-27.70%
2.23
2.52
-11.51%
Interest
2.58
3.69
-30.08%
3.10
3.43
-9.62%
2.99
3.39
-11.80%
4.08
5.19
-21.39%
Depreciation
5.40
6.15
-12.20%
5.81
6.12
-5.07%
5.87
6.46
-9.13%
6.08
6.38
-4.70%
PBT
24.08
11.82
103.72%
28.09
-5.93
-
31.98
0.91
3,414.29%
45.34
16.07
182.14%
Tax
6.05
0.70
764.29%
6.48
0.00
0
-1.34
8.05
-
7.45
6.08
22.53%
PAT
18.03
11.12
62.14%
21.60
-5.93
-
33.32
-7.15
-
37.89
9.99
279.28%
PATM
13.85%
11.70%
15.85%
-7.59%
23.83%
-7.34%
24.21%
10.09%
EPS
6.49
3.92
65.56%
7.49
-2.01
-
11.79
-2.40
-
12.66
3.41
271.26%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Net Sales
562.80
469.48
335.66
349.94
398.52
377.29
292.95
404.67
302.67
164.13
154.80
Net Sales Growth
52.33%
39.87%
-4.08%
-12.19%
5.63%
28.79%
-27.61%
33.70%
84.41%
6.03%
 
Cost Of Goods Sold
185.94
147.40
130.13
153.55
153.15
134.37
79.02
92.26
80.41
68.43
64.51
Gross Profit
376.86
322.08
205.52
196.39
245.36
242.92
213.92
312.42
222.26
95.70
90.29
GP Margin
66.96%
68.60%
61.23%
56.12%
61.57%
64.39%
73.02%
77.20%
73.43%
58.31%
58.33%
Total Expenditure
417.72
358.98
307.77
331.75
336.29
294.71
228.64
269.35
211.54
152.17
134.66
Power & Fuel Cost
-
27.23
19.78
18.24
20.35
14.23
12.74
13.88
11.11
9.97
8.67
% Of Sales
-
5.80%
5.89%
5.21%
5.11%
3.77%
4.35%
3.43%
3.67%
6.07%
5.60%
Employee Cost
-
65.10
58.55
58.00
62.97
58.22
50.03
53.18
39.83
30.84
27.97
% Of Sales
-
13.87%
17.44%
16.57%
15.80%
15.43%
17.08%
13.14%
13.16%
18.79%
18.07%
Manufacturing Exp.
-
46.62
36.56
32.66
37.22
31.08
21.62
27.60
26.64
17.04
12.03
% Of Sales
-
9.93%
10.89%
9.33%
9.34%
8.24%
7.38%
6.82%
8.80%
10.38%
7.77%
General & Admin Exp.
-
46.78
46.09
46.09
39.95
29.05
33.12
27.57
15.80
13.19
12.46
% Of Sales
-
9.96%
13.73%
13.17%
10.02%
7.70%
11.31%
6.81%
5.22%
8.04%
8.05%
Selling & Distn. Exp.
-
17.47
11.36
13.97
17.06
19.13
23.38
31.40
26.90
5.47
5.71
% Of Sales
-
3.72%
3.38%
3.99%
4.28%
5.07%
7.98%
7.76%
8.89%
3.33%
3.69%
Miscellaneous Exp.
-
8.37
5.30
9.24
5.58
8.63
8.73
23.47
10.84
7.23
5.71
% Of Sales
-
1.78%
1.58%
2.64%
1.40%
2.29%
2.98%
5.80%
3.58%
4.41%
2.13%
EBITDA
145.08
110.50
27.89
18.19
62.23
82.58
64.31
135.32
91.13
11.96
20.14
EBITDA Margin
25.78%
23.54%
8.31%
5.20%
15.62%
21.89%
21.95%
33.44%
30.11%
7.29%
13.01%
Other Income
20.32
11.82
11.81
8.60
8.25
8.37
14.20
26.50
10.83
2.78
1.31
Interest
12.75
14.89
17.43
21.37
17.98
19.00
20.09
21.23
13.63
9.96
6.15
Depreciation
23.16
24.22
24.72
28.25
25.56
20.31
15.00
11.89
12.36
10.31
8.35
PBT
129.49
83.21
-2.45
-22.83
26.94
51.63
43.42
128.71
75.97
-5.53
6.96
Tax
18.64
6.80
14.14
1.83
11.88
9.10
-16.10
10.80
21.13
2.70
4.25
Tax Rate
14.39%
8.17%
-143.12%
-3.57%
44.10%
17.63%
-37.08%
8.39%
27.81%
-48.82%
61.06%
PAT
110.84
76.86
-23.06
-51.07
15.45
45.51
59.53
117.88
42.21
-11.03
-0.59
PAT before Minority Interest
112.01
76.40
-24.01
-53.13
15.06
42.53
59.52
117.90
54.84
-8.23
2.71
Minority Interest
1.17
0.46
0.95
2.06
0.39
2.98
0.01
-0.02
-12.63
-2.80
-3.30
PAT Margin
19.69%
16.37%
-6.87%
-14.59%
3.88%
12.06%
20.32%
29.13%
13.95%
-6.72%
-0.38%
PAT Growth
1,280.32%
-
-
-
-66.05%
-23.55%
-49.50%
179.27%
-
-
 
EPS
37.70
26.14
-7.84
-17.37
5.26
15.48
20.25
40.10
14.36
-3.75
-0.20

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Shareholder's Funds
362.67
288.86
315.31
372.13
360.59
309.44
250.55
124.45
144.40
129.82
Share Capital
14.58
14.44
14.43
14.42
14.42
14.42
4.59
2.29
2.29
2.29
Total Reserves
347.79
261.69
287.63
343.02
334.17
288.94
245.21
122.16
142.11
127.53
Non-Current Liabilities
29.24
77.03
97.43
154.05
131.41
71.52
125.39
145.65
48.11
24.27
Secured Loans
15.05
42.54
83.59
114.68
110.44
101.79
135.21
135.37
40.32
17.78
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
21.61
14.97
20.08
67.43
58.77
4.06
6.31
2.73
2.67
1.79
Current Liabilities
245.20
194.07
229.77
227.85
230.09
194.60
155.98
103.56
86.16
108.48
Trade Payables
77.49
64.90
45.79
64.58
62.14
56.33
42.72
40.09
27.49
19.77
Other Current Liabilities
47.84
39.61
58.53
43.72
49.90
33.12
47.42
29.38
20.79
56.62
Short Term Borrowings
81.24
67.34
101.46
97.47
96.30
104.33
60.21
29.86
37.13
29.34
Short Term Provisions
38.63
22.22
23.98
22.07
21.75
0.81
5.63
4.23
0.75
2.75
Total Liabilities
632.95
556.26
639.76
753.35
721.79
575.57
531.94
384.64
307.14
288.24
Net Block
223.37
263.13
238.25
231.31
262.93
128.89
103.73
96.88
89.81
168.10
Gross Block
367.61
387.06
338.52
308.92
330.73
166.48
128.99
114.18
103.03
221.97
Accumulated Depreciation
144.25
123.93
100.27
77.61
67.80
37.59
25.25
17.30
13.21
53.77
Non Current Assets
264.40
293.70
365.69
418.61
391.42
291.56
226.13
202.38
202.88
194.84
Capital Work in Progress
15.91
1.62
45.02
34.56
56.91
70.77
21.58
3.50
5.49
5.94
Non Current Investment
0.49
0.43
0.37
0.29
0.25
71.52
74.41
81.82
89.76
14.60
Long Term Loans & Adv.
19.36
21.05
29.33
81.35
70.47
19.60
18.64
6.80
4.51
6.20
Other Non Current Assets
2.10
2.07
24.01
3.82
0.86
0.78
7.77
13.39
13.31
0.01
Current Assets
368.55
262.57
274.07
334.74
330.38
284.01
295.61
182.27
104.26
93.40
Current Investments
0.00
0.00
2.78
0.00
0.00
0.00
1.15
1.06
1.00
0.80
Inventories
123.65
87.38
130.14
159.48
162.27
128.58
87.67
51.18
38.91
27.97
Sundry Debtors
95.23
69.83
41.65
87.09
68.01
69.77
65.54
68.72
44.57
43.01
Cash & Bank
71.70
59.83
58.33
33.61
44.53
33.11
91.13
32.66
2.49
4.79
Other Current Assets
77.98
6.55
4.08
11.25
55.56
52.55
50.12
28.65
17.28
16.84
Short Term Loans & Adv.
59.93
38.97
37.09
43.32
42.69
43.41
31.14
18.31
12.90
10.22
Net Current Assets
123.36
68.49
44.30
106.90
100.29
89.42
139.63
78.71
18.10
-15.08
Total Assets
632.95
556.27
639.76
753.35
721.80
575.57
531.93
384.65
307.14
288.24

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Cash From Operating Activity
40.90
105.35
116.11
43.44
62.60
34.46
90.34
59.26
1.91
4.44
PBT
83.21
-9.87
-51.31
26.94
51.63
43.42
128.71
75.97
-5.53
6.96
Adjustment
42.97
81.50
119.25
43.18
39.61
34.01
31.05
27.02
24.10
14.71
Changes in Working Capital
-82.50
32.70
44.95
-17.38
-15.12
-29.03
-36.56
-25.46
-14.42
-14.47
Cash after chg. in Working capital
43.67
104.33
112.90
52.75
76.12
48.40
123.20
77.54
4.16
7.21
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-2.77
1.02
3.21
-9.31
-13.52
-13.94
-32.86
-18.28
-2.25
-2.77
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-0.16
-15.50
-55.41
-26.04
-41.55
-43.66
-96.58
-101.14
6.52
-13.38
Net Fixed Assets
5.15
-13.76
-37.00
43.97
-138.56
-83.89
-136.01
-3.33
90.14
-15.75
Net Investments
-0.06
11.72
-2.36
-0.04
58.91
3.87
116.82
-76.31
-75.58
-0.61
Others
-5.25
-13.46
-16.05
-69.97
38.10
36.36
-77.39
-21.50
-8.04
2.98
Cash from Financing Activity
-50.87
-90.85
-41.38
-21.58
-1.14
-47.45
12.22
88.82
-12.11
10.42
Net Cash Inflow / Outflow
-10.12
-1.00
19.32
-4.17
19.90
-56.65
5.99
46.93
-3.67
1.48
Opening Cash & Equivalents
16.75
17.75
-1.61
2.29
-18.22
38.42
32.44
-14.50
-10.82
3.30
Closing Cash & Equivalent
6.63
16.75
17.75
-1.88
2.29
-18.22
38.42
32.44
-14.50
4.79

Financial Ratios

Consolidated /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Book Value (Rs.)
124.23
95.63
104.67
123.91
120.84
105.16
87.07
45.22
52.47
47.18
ROA
12.85%
-4.01%
-7.63%
2.04%
6.56%
10.75%
25.73%
15.85%
-2.76%
0.99%
ROE
23.93%
-8.30%
-16.11%
4.27%
13.05%
21.92%
64.77%
40.79%
-6.00%
2.08%
ROCE
21.97%
1.58%
-5.25%
7.50%
12.62%
12.98%
40.16%
33.86%
1.96%
6.18%
Fixed Asset Turnover
1.24
0.93
1.08
1.25
1.52
1.98
3.33
2.79
1.02
0.87
Receivable days
64.16
60.61
67.14
71.03
66.65
84.30
60.55
68.24
96.46
90.86
Inventory Days
82.04
118.27
151.04
147.34
140.69
134.72
62.62
54.27
73.67
57.38
Payable days
176.30
155.24
131.18
150.99
160.90
86.23
63.57
60.55
60.91
51.44
Cash Conversion Cycle
-30.10
23.64
87.00
67.38
46.44
132.79
59.60
61.95
109.22
96.80
Total Debt/Equity
0.30
0.48
0.72
0.66
0.66
0.73
0.87
1.39
0.60
0.70
Interest Cover
6.59
0.43
-1.40
2.50
3.72
3.16
7.06
6.57
0.45
2.13

News Update:


  • Fermenta Biotech gets nod to raise Rs 150 crore
    10th Dec 2025, 15:43 PM

    The Board of Directors of the Company, at its meeting held on December 10, 2025, has, inter alia, considered and approved the same

    Read More
  • Fermenta Biotech makes further investment in FESPL
    25th Oct 2025, 09:57 AM

    There will be no change in the percentage of shareholding of the company in FESPL

    Read More
  • Fermenta Biotech to sell environmental solutions business to subsidiary
    19th Sep 2025, 16:00 PM

    The initiative also aligns with the company’s vision to leverage its expertise and capabilities to create solutions that benefit both business and society

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.